ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $552.77 million. The enterprise value is $331.61 million.

Market Cap	552.77M
Enterprise Value	331.61M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 302.06 million shares outstanding. The number of shares has increased by 20.33% in one year.

Current Share Class	205.20M
Shares Outstanding	302.06M
Shares Change (YoY)	+20.33%
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	12.36%
Owned by Institutions (%)	15.26%
Float	156.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	621.79
Forward PS	984.75
PB Ratio	2.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	373.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.06, with a Debt / Equity ratio of 0.01.

Current Ratio	9.06
Quick Ratio	8.71
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8,871.16

Financial Efficiency

Return on equity (ROE) is -49.37% and return on invested capital (ROIC) is -32.91%.

Return on Equity (ROE)	-49.37%
Return on Assets (ROA)	-30.15%
Return on Invested Capital (ROIC)	-32.91%
Return on Capital Employed (ROCE)	-63.16%
Weighted Average Cost of Capital (WACC)	13.51%
Revenue Per Employee	$3,848
Profits Per Employee	-$312,939
Employee Count	231
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-177,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +137.35% in the last 52 weeks. The beta is 1.70, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	+137.35%
50-Day Moving Average	1.81
200-Day Moving Average	2.23
Relative Strength Index (RSI)	54.56
Average Volume (20 Days)	1,308,479

Short Selling Information

The latest short interest is 18.03 million, so 5.97% of the outstanding shares have been sold short.

Short Interest	18.03M
Short Previous Month	19.24M
Short % of Shares Out	5.97%
Short % of Float	11.50%
Short Ratio (days to cover)	21.17

Income Statement

In the last 12 months, ProKidney had revenue of $889,000 and -$72.29 million in losses. Loss per share was -$0.53.

Revenue	889,000
Gross Profit	889,000
Operating Income	-168.55M
Pretax Income	-156.46M
Net Income	-72.29M
EBITDA	-161.92M
EBIT	-168.55M
Loss Per Share	-$0.53

Full Income Statement

Balance Sheet

The company has $224.94 million in cash and $3.78 million in debt, giving a net cash position of $221.16 million or $0.73 per share.

Cash & Cash Equivalents	224.94M
Total Debt	3.78M
Net Cash	221.16M
Net Cash Per Share	$0.73
Equity (Book Value)	263.10M
Book Value Per Share	-7.21
Working Capital	208.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$132.21 million and capital expenditures -$17.85 million, giving a free cash flow of -$150.06 million.

Operating Cash Flow	-132.21M
Capital Expenditures	-17.85M
Depreciation & Amortization	6.63M
Net Borrowing	-17,000
Free Cash Flow	-150.06M
FCF Per Share	-$0.50

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-18,959.73%
Pretax Margin	-17,599.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.33%
Shareholder Yield	-20.33%
Earnings Yield	-13.08%
FCF Yield	-27.15%

Analyst Forecast

The average price target for ProKidney is $6.25, which is 241.53% higher than the current price. The consensus rating is "Buy".

Price Target	$6.25
Price Target Difference	241.53%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	327.50%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.51
Piotroski F-Score	1